Steven J. Meyer, Director at Insys Therapeutics, Inc. (INSY), bought 8,000 shares at $12.21 ($98K) on 2017-05-18, disclosed to the SEC on 2017-05-18.
Seasonal purchase ($98k) by Director — this insider has traded INSY in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AKRX | BUY | 2019-05-30 | $38K | — | Filing → |
| AKRX | BUY | 2019-05-22 | $123K | — | Filing → |
| INSY | BUY | 2016-11-07 | $108K | — | Filing → |